https://www.marketscreener.com/quote/stock/IMMUNOME-INC-113170562/news/Immunome-to-Present-Preclinical-Data-for-IM-3050-Its-Lead-Radioligand-Therapy-Candidate-at-2024-Am-46386295/?utm_source=telegram&utm_medium=social&utm_campaign=share